Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy

PURPOSE: To prospectively compare the effects of half-dose verteporfin (3 mg/m(2)) photodynamic therapy (1/2 PDT) with those of one-third-dose verteporfin (2 mg/m(2)) PDT (1/3 PDT) for chronic central serous chorioretinopathy (CSC). METHODS: Sixteen eyes of 16 consecutive patients with chronic CSC w...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Uetani, R, Ito, Y, Oiwa, K, Ishikawa, K, Terasaki, H
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2012
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351069/
https://ncbi.nlm.nih.gov/pubmed/22573069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2012.66
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items